ITRM20040561A1 - Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile. - Google Patents

Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.

Info

Publication number
ITRM20040561A1
ITRM20040561A1 IT000561A ITRM20040561A ITRM20040561A1 IT RM20040561 A1 ITRM20040561 A1 IT RM20040561A1 IT 000561 A IT000561 A IT 000561A IT RM20040561 A ITRM20040561 A IT RM20040561A IT RM20040561 A1 ITRM20040561 A1 IT RM20040561A1
Authority
IT
Italy
Prior art keywords
carnitine
sildenafil
propionyl
acetyl
treatment
Prior art date
Application number
IT000561A
Other languages
English (en)
Italian (it)
Inventor
Giorgio Cavallini
Aleardo Koverech
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000561A priority Critical patent/ITRM20040561A1/it
Publication of ITRM20040561A1 publication Critical patent/ITRM20040561A1/it
Priority to JP2007540521A priority patent/JP5080263B2/ja
Priority to PT05798477T priority patent/PT1811988E/pt
Priority to KR1020077013019A priority patent/KR101455275B1/ko
Priority to DE602005019251T priority patent/DE602005019251D1/de
Priority to DK05798477.5T priority patent/DK1811988T3/da
Priority to AT05798477T priority patent/ATE456950T1/de
Priority to US11/719,011 priority patent/US8003652B2/en
Priority to EP05798477A priority patent/EP1811988B1/en
Priority to PCT/EP2005/011238 priority patent/WO2006050794A1/en
Priority to ES05798477T priority patent/ES2339265T3/es
Priority to CA2585654A priority patent/CA2585654C/en
Priority to MX2007005518A priority patent/MX2007005518A/es
Priority to PL05798477T priority patent/PL1811988T3/pl
Priority to SI200530953T priority patent/SI1811988T1/sl
Priority to CY20101100362T priority patent/CY1110239T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000561A 2004-11-11 2004-11-11 Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile. ITRM20040561A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT000561A ITRM20040561A1 (it) 2004-11-11 2004-11-11 Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
SI200530953T SI1811988T1 (sl) 2004-11-11 2005-10-19 Uporaba acetil l-karnitina v kombinaciji s propionil l-karnitinom in sildenafilom za zdravljenje erektilne disfunkcije
AT05798477T ATE456950T1 (de) 2004-11-11 2005-10-19 Verwendung von acetyl l-carnitin in kombination mit propionyl l-carnitin und sildenafil zur behandlung von erektiler dysfunktion
EP05798477A EP1811988B1 (en) 2004-11-11 2005-10-19 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction
KR1020077013019A KR101455275B1 (ko) 2004-11-11 2005-10-19 발기 부전의 치료를 위한 아세틸 엘 카르니틴과 프로피오닐엘 카르니틴 및 실데나필과의 병용된 용도
DE602005019251T DE602005019251D1 (de) 2004-11-11 2005-10-19 Verwendung von acetyl l-carnitin in kombination mit propionyl l-carnitin und sildenafil zur behandlung von erektiler dysfunktion
DK05798477.5T DK1811988T3 (da) 2004-11-11 2005-10-19 Anvendelse af acetyl-L-carnitin i kombination med propionyl-L-carnitin og sildenafil til behandling af erektil dysfunktion
JP2007540521A JP5080263B2 (ja) 2004-11-11 2005-10-19 勃起不全の治療のためのプロピオニルl−カルニチンおよびシルデナフィルと組み合わせてのアセチルl−カルニチンの使用
US11/719,011 US8003652B2 (en) 2004-11-11 2005-10-19 Use of acetyl L-carnitine in combination with propionyl L-carnitine and Sildenafil for the treatment of erectile dysfunction
PT05798477T PT1811988E (pt) 2004-11-11 2005-10-19 Utilização de acetil l-carnitina em combinação com propionilo l-carnitina e sildenafil para o tratamento da disfunção eréctil
PCT/EP2005/011238 WO2006050794A1 (en) 2004-11-11 2005-10-19 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction
ES05798477T ES2339265T3 (es) 2004-11-11 2005-10-19 Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de la difuncion erectil.
CA2585654A CA2585654C (en) 2004-11-11 2005-10-19 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction
MX2007005518A MX2007005518A (es) 2004-11-11 2005-10-19 Uso de acetil l-carnitina en combinacion con propionil l-carnitina y sildenafil para el tratamiento de disfuncion erectil.
PL05798477T PL1811988T3 (pl) 2004-11-11 2005-10-19 Zastosowanie acetylo-L-karnityny w połączeniu z propionylo-L-karnityną i sildenafilem do leczenia zaburzenia erekcji
CY20101100362T CY1110239T1 (el) 2004-11-11 2010-04-23 Χρηση ακετυλο-l-kapnιτινη σε συνδυασμο με προπιονυλο-l-καρνιτινη και σιλδεναφιλη για τη θεραπευτικη αγωγη της στυτικης δυσλειτουργιας

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000561A ITRM20040561A1 (it) 2004-11-11 2004-11-11 Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.

Publications (1)

Publication Number Publication Date
ITRM20040561A1 true ITRM20040561A1 (it) 2005-02-11

Family

ID=35501123

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000561A ITRM20040561A1 (it) 2004-11-11 2004-11-11 Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.

Country Status (16)

Country Link
US (1) US8003652B2 (enExample)
EP (1) EP1811988B1 (enExample)
JP (1) JP5080263B2 (enExample)
KR (1) KR101455275B1 (enExample)
AT (1) ATE456950T1 (enExample)
CA (1) CA2585654C (enExample)
CY (1) CY1110239T1 (enExample)
DE (1) DE602005019251D1 (enExample)
DK (1) DK1811988T3 (enExample)
ES (1) ES2339265T3 (enExample)
IT (1) ITRM20040561A1 (enExample)
MX (1) MX2007005518A (enExample)
PL (1) PL1811988T3 (enExample)
PT (1) PT1811988E (enExample)
SI (1) SI1811988T1 (enExample)
WO (1) WO2006050794A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010222347A (ja) * 2009-02-24 2010-10-07 Daiichi Sankyo Healthcare Co Ltd Pde5阻害剤及びカルニチンを含有する医薬組成物
WO2012000634A1 (de) 2010-06-29 2012-01-05 Georg Bambach Pharmazeutische zusammensetzung zur behandlung von erektiler dysfunktion
WO2018070971A1 (ru) * 2016-10-10 2018-04-19 Товарыство З Обмэжэною Видповидальнистю Науково-Выробныча Фирма "Микрохим" Фармацевтическая композиция в форме оромукозного спрея для лечения эректильной дисфункции и легочной артериальной гипертензии

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077260B1 (en) 1999-08-13 2010-03-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Parvovirus NS1 variants
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
JP2001233770A (ja) * 2000-02-23 2001-08-28 Dountsuendorufaa Udo 勃起機能不全治療用の経口薬の組合わせ
ITRM20010621A1 (it) * 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.

Also Published As

Publication number Publication date
US8003652B2 (en) 2011-08-23
DE602005019251D1 (de) 2010-03-25
CA2585654C (en) 2013-04-02
WO2006050794A1 (en) 2006-05-18
JP2008531466A (ja) 2008-08-14
CA2585654A1 (en) 2006-05-18
ATE456950T1 (de) 2010-02-15
PL1811988T3 (pl) 2010-07-30
PT1811988E (pt) 2010-04-08
EP1811988A1 (en) 2007-08-01
SI1811988T1 (sl) 2010-10-29
DK1811988T3 (da) 2010-05-17
EP1811988B1 (en) 2010-02-03
CY1110239T1 (el) 2015-01-14
ES2339265T3 (es) 2010-05-18
MX2007005518A (es) 2007-05-18
JP5080263B2 (ja) 2012-11-21
US20080090906A1 (en) 2008-04-17
KR101455275B1 (ko) 2014-10-27
KR20070085961A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
IN2004CH02386A (enExample)
AR059817A1 (es) "uso de sacaridos no digeribles para proporcionarle a un nino el mejor comienzo luego del nacimiento"
ITFI20020145A1 (it) Dispositivo per il trattamento chirurgico del prolasso femminile.
CL2008002207A1 (es) Composicion farmaceutica que comprende inmunosupresores para la mejora del efecto en el uso de un antagonista de interleucina-6 (il-6) para el tratamiento de enfermedades relacionadas con il-6 (div. sol. 896-04).
ATE381951T1 (de) Medizinischer ballon
NO20092143L (no) Anvendelse av testosteron og en 5-HT1A-agonist ved behandling av seksuell dysfunksjon
MX347237B (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
ITRM20040561A1 (it) Uso della acetil l-carnitina in combinazione con propionil l-carnitina e sildenafil per il trattamento della disfunzione erettile.
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
WO2009099543A3 (en) Device for perineal massage and method of use
BR0013272B1 (pt) Uso de um inibidor de aromatase esteroidal
BRPI0416202A (pt) formulações inibidoras de fosfodiesterase v
SI1492521T1 (sl) Kombinirana uporaba l-karnitina, acetil l-karnitina in propil l-karnitina za zdravljenje oligoastenoteratospermije
MXPA05009718A (es) Uso de un fibrato y orlistato para el tratamiento de obesidad.
AU303261S (en) A waterless urinal
AU303260S (en) A waterless urinal
GB0401292D0 (en) Synthesis of spongosine
ITRM20040606A1 (it) Uso della acetil l-carnitina per il trattamento della sindrome fibromialgica.
TW200605891A (en) Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
Ковальчук et al. Êóëüòóðà ðîñ³éñüêî¿ ìîâè â Óêðà¿ í³
PH12014500597A1 (en) Pelvic immobilizer
NAKAMURA Reflections on Learning from a Study Leave: One Year Later
徐平元 A Pragmatic Study of Chinese English Learners' Realization Strategies of Requests in Letters
AR051430A4 (es) Complemento de anillo peneano para mantener la ereccion y mejorado para favorecer la eyaculacion
AR060559A1 (es) Silla terapeutica para kinesiologia y masajistas